Autopilot 2.0 Chain AI agents into full outbound flows Read more →
Product
AI Sales Agents Prospector Intent & Signals Visitor Tracking Reply Handler Email Automation LinkedIn Automation Autopilot
Solutions
TAM sourcing Automated outbound Sales RevOps Enterprise Startups
Resources
The Report Blog Salestools University Guides GPT Prompts ROI Calculator Help Center
Company
Our Team Careers Customers Partner Program Pricing Changelog
Language
Get a demo Start free trial Log in

O relatório

Análises profundas sobre financiamento de empresas, estratégias de crescimento e insights de mercado dos negócios mais inovadores do mundo

205 relatórios e mais

Atualizado diariamente com as últimas inteligências de mercado
Biotech
CRISPR Therapeutics

CRISPR Therapeutics raises $337M Follow-on Offering at $8B valuation

CRISPR Therapeutics raises $337M in Follow-on Offering at $8B valuation. Gene-based medicines using CRISPR/Cas9...

Editorial Team
Sep 4, 2024
0 min read•$337M
Fundraising
CRISPR Therapeutics

CRISPR Therapeutics Raises $337M in Follow-on Offering

CRISPR Therapeutics, a Biotech company based in Aeschenvorstadt 36, Basel 4051, Switzerland, has raised $337M in Follow-on Offering at a $8B valuation led by Versant Ventures, Bayer, Vertex Pharmaceuticals.

Fundraising News Team
Sep 4, 2024
0 min read
Biotech
Intellia Therapeutics

Intellia Therapeutics raises $350M Follow-on Offering at $4.5B valuation

Intellia Therapeutics raises $350M in Follow-on Offering at $4.5B valuation. In vivo CRISPR gene editing...

Editorial Team
Jun 21, 2024
0 min read•$350M
Fundraising
Intellia Therapeutics

Intellia Therapeutics Raises $350M in Follow-on Offering

Intellia Therapeutics, a Biotech company based in 40 Erie Street, Cambridge, MA 02139, has raised $350M in Follow-on Offering at a $4.5B valuation led by Atlas Venture, Novartis Venture Fund, Venrock, Lilly Asia Ventures.

Fundraising News Team
Jun 21, 2024
0 min read
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read•$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read•$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read•$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read•$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min read•$205M
Página 1

Mostrando 9 relatórios • Página 1 • Categoria: all

Fique à frente do mercado

Receba insights semanais em sua caixa de entrada. Sem spam, apenas inteligência.